Target Gene/Pathway
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z other
| No. | KEGG PATHWAY * On map, Yellow: Drug target, Red: Disease-related |
KEGG GENES * [Number of genes] |
KEGG DRUG * | DrugBank | Disease ID * [Number of diseases] |
| 1 | Calcium signaling pathway |
[2] EDNRA, EDNRB | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 2 | cAMP signaling pathway |
[1] EDNRA | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 3 | cGMP-PKG signaling pathway |
[2] EDNRA, EDNRB | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 4 | Cytokine-cytokine receptor interaction |
[1] EPOR | D03231 | Erythropoietin | [9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 5 | Hematopoietic cell lineage |
[1] EPOR | D03231 | Erythropoietin | [9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 6 | JAK-STAT signaling pathway |
[1] EPOR | D03231 | Erythropoietin | [9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 7 | Melanogenesis |
[1] EDNRB | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 8 | Neuroactive ligand-receptor interaction |
[2] EDNRA, EDNRB | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 9 | Pathways in cancer |
[2] EDNRA, EDNRB | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| [1] EPOR | D03231 | Erythropoietin | [9] 2, 6, 13, 22, 46, 47, 70, 95, 96 | ||
| 10 | PI3K-Akt signaling pathway |
[1] EPOR | D03231 | Erythropoietin | [9] 2, 6, 13, 22, 46, 47, 70, 95, 96 |
| 11 | Relaxin signaling pathway |
[1] EDNRB | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 12 | Renin secretion |
[1] EDNRA | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 | |||||
| 13 | Vascular smooth muscle contraction |
[1] EDNRA | D01227 | Bosentan | [10] 13, 41, 47, 51, 84, 85, 86, 88, 210, 211 |
| D07538 |